Home › Funds › Elmind Capital, LP › COGT
Elmind Capital, LP position in COGT
COGENT BIOSCIENCES INC · Health Care
Elmind Capital, LP reported holding 1,170,740 shares of COGT (COGENT BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$45.3M, representing 11.38% of its reported portfolio and ranking #1 among its reported holdings. Elmind Capital, LP has disclosed COGT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Elmind Capital, LP's COGT position evolved
Elmind Capital, LP first disclosed a stake in COGT in Q4 2025 at 1,170,740 shares (US$41.6M). The position peaked in Q2 2026 at 1,170,740 shares, worth US$45.3M. Across 3 filings, Elmind Capital, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,170,740 shares valued at US$45.3M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 1.17M | $41.58M | New |
| Q1 2026 | 1.17M | $45.06M | Hold |
| Q2 2026 | 1.17M | $45.31M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COGT and 13F data
COGT (COGENT BIOSCIENCES INC) is a Health Care company. 59 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COGT
- Fairmount Funds Management LLC 5.50M sh · $212.98M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 5.01M sh · $193.74M · Q2 2026
- TCG Crossover Management, LLC 4.85M sh · $187.87M · Q2 2026
- Kynam Capital Management, LP 3.67M sh · $141.92M · Q2 2026
- Commodore Capital LP 3.05M sh · $118.03M · Q2 2026
- Octagon Capital Advisors LP 2.35M sh · $90.94M · Q2 2026
- RTW INVESTMENTS, LP 2.31M sh · $89.36M · Q2 2026
- Deep Track Capital, LP 2.00M sh · $77.40M · Q2 2026
- Siren, L.L.C. 1.86M sh · $71.95M · Q2 2026
- Venrock Adviser, LLC 1.64M sh · $63.55M · Q2 2026
- EMERALD ADVISERS, LLC 1.60M sh · $62.05M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 1.28M sh · $49.56M · Q2 2026
More on Elmind Capital, LP
FAQ
How long has Elmind Capital, LP held COGT?
Elmind Capital, LP has disclosed COGT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Elmind Capital, LP's current position in COGT?
As of Q2 2026, Elmind Capital, LP holds 1.17M shares of COGT (COGENT BIOSCIENCES INC), valued at $45.31M, representing 11.38% of its reported portfolio and ranking #1.
Has Elmind Capital, LP been buying or selling COGT?
In the latest 13F filing (Q2 2026), Elmind Capital, LP held unchanged its position in COGT. The position peaked in Q2 2026 at 1.17M shares.
Which other funds hold COGT?
Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, among 59 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.